138 related articles for article (PubMed ID: 10895341)
1. DNA testing for fragile X syndrome in 255 males from special schools in Singapore.
Tan BS; Law HY; Zhao Y; Yoon CS; Ng IS
Ann Acad Med Singap; 2000 Mar; 29(2):207-12. PubMed ID: 10895341
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
[TBL] [Abstract][Full Text] [Related]
3. Screening for the fragile X syndrome among mentally retarded males by hair root analysis.
Tunçbilek E; Alikasifoğlu M; Aktas D; Duman F; Yanik H; Anar B; Oostra B; Willemsen R
Am J Med Genet; 2000 Nov; 95(2):105-7. PubMed ID: 11078558
[TBL] [Abstract][Full Text] [Related]
4. A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males.
Haddad LA; Mingroni-Netto RC; Vianna-Morgante AM; Pena SD
Hum Genet; 1996 Jun; 97(6):808-12. PubMed ID: 8641701
[TBL] [Abstract][Full Text] [Related]
5. A methylation PCR approach for detection of fragile X syndrome.
Panagopoulos I; Lassen C; Kristoffersson U; Aman P
Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic analysis of mentally retarded males with features of the fragile-X syndrome.
Butler MG; Pratesi R; Vnencak-Jones CL
J Intellect Disabil Res; 1995 Dec; 39 ( Pt 6)(Pt 6):544-53. PubMed ID: 8746743
[TBL] [Abstract][Full Text] [Related]
7. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
[TBL] [Abstract][Full Text] [Related]
8. Non-radioactive DNA diagnosis for the fragile X syndrome in mentally retarded Japanese males.
Nanba E; Kohno Y; Matsuda A; Yano M; Sato C; Hashimoto K; Koeda T; Yoshino K; Kimura M; Maeoka Y
Brain Dev; 1995; 17(5):317-21; discussion 323-4. PubMed ID: 8579216
[TBL] [Abstract][Full Text] [Related]
9. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome.
Meijer H; de Graaff E; Merckx DM; Jongbloed RJ; de Die-Smulders CE; Engelen JJ; Fryns JP; Curfs PM; Oostra BA
Hum Mol Genet; 1994 Apr; 3(4):615-20. PubMed ID: 8069307
[TBL] [Abstract][Full Text] [Related]
10. Apparently unstable normal FMR1 alleles in nine developmentally delayed patients: implications for molecular diagnosis of the fragile X syndrome.
Tzountzouris J; Kennedy D; Skuterud M; Connolly-Wilson M; Holden JJ; Lin CC; Mak-Tam E; Somerville MJ; Summers AM; Allingham-Hawkins DJ
Genet Test; 2000; 4(3):235-9. PubMed ID: 11142752
[TBL] [Abstract][Full Text] [Related]
11. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.
de Vries BB; van den Ouweland AM; Mohkamsing S; Duivenvoorden HJ; Mol E; Gelsema K; van Rijn M; Halley DJ; Sandkuijl LA; Oostra BA; Tibben A; Niermeijer MF
Am J Hum Genet; 1997 Sep; 61(3):660-7. PubMed ID: 9326332
[TBL] [Abstract][Full Text] [Related]
12. Implication of screening for FMR1 and FMR2 gene mutation in individuals with nonspecific mental retardation in Taiwan.
Tzeng CC; Tzeng PY; Sun HS; Chen RM; Lin SJ
Diagn Mol Pathol; 2000 Jun; 9(2):75-80. PubMed ID: 10850542
[TBL] [Abstract][Full Text] [Related]
13. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
14. Fragile X syndrome (review).
Pimentel MM
Int J Mol Med; 1999 Jun; 3(6):639-45. PubMed ID: 10341296
[TBL] [Abstract][Full Text] [Related]
15. Two new cases of FMR1 deletion associated with mental impairment.
Hirst M; Grewal P; Flannery A; Slatter R; Maher E; Barton D; Fryns JP; Davies K
Am J Hum Genet; 1995 Jan; 56(1):67-74. PubMed ID: 7825604
[TBL] [Abstract][Full Text] [Related]
16. Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation.
Milà M; Sànchez A; Badenas C; Brun C; Jiménez D; Villa MP; Castellví-Bel S; Estivill X
Hum Genet; 1997 Oct; 100(5-6):503-7. PubMed ID: 9341861
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnosis of the fragile X and FRAXE syndromes in patients with mental retardation of unknown cause in Mexico.
González-del Angel A; Vidal S; Saldaña Y; del Castillo V; Angel Alcántara M; Macías M; Pedro Luna J; Orozco L
Ann Genet; 2000; 43(1):29-34. PubMed ID: 10818218
[TBL] [Abstract][Full Text] [Related]
18. The fragile X syndrome.
de Vries BB; Halley DJ; Oostra BA; Niermeijer MF
J Med Genet; 1998 Jul; 35(7):579-89. PubMed ID: 9678703
[TBL] [Abstract][Full Text] [Related]
19. Pilot fragile X screening in normal population of Taiwan.
Tzeng CC; Cho WC; Kuo PL; Chen RM
Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
[TBL] [Abstract][Full Text] [Related]
20. Applicability of a checklist for clinical screening of the fragile X syndrome.
Arvio M; Peippo M; Simola KO
Clin Genet; 1997 Oct; 52(4):211-5. PubMed ID: 9383025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
